Global MicroRNA Market 2012 - 2016
Published Date » 2013-09-27
No. Of Pages » 56
TechNavio's analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the growth of this market.
TechNavio's report, Global MicroRNA Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, and the ROW; it also covers the Global MicroRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Alnylam Pharmaceuticals Inc., Exiqon A/S, and Santaris Pharma A/S.
Other vendors mentioned in the report are Access Pharmaceuticals, Aegera Therapeutics Inc., Affymetrix Inc., Agilent Technologies, Antisense Pharma GmbH, Aparna Biosciences Corp., Applied Biological Materials Inc., Arrowhead Research Corp., AstraZeneca Pharmaceuticals LP, Asuragen Inc., Benitec Biopharma Ltd., BioCancell Therapeutics Inc., Biogen Idec Inc., CBC Comprehensive Biomarker Center GmbH, Clontech Laboratories Inc., Dicerna Pharmaceuticals Inc., Eli Lilly and Co., EMD4Biosciences, Expression Genetics Inc., F. Hoffman-La Roche AG, Fluidigm Corp., GeneCopoeia Inc., GenoSensor Corp., Gensignia Inc., Groove Biopharma, GlaxoSmithKline, HTG Molecular Diagnostics Inc., Idera Pharmaceuticals Inc., Illumina Inc., InteRNA Technologies B.V., Isis Pharmaceuticals Inc., LC Sciences Llc, Life Technologies Corp., Merck & Co. Inc., miRagen Therapeutics Inc., Mirna Therapeutics Inc., NanoString Technologies Inc., Norgen Biotek Corp., Novartis AG, Pfizer Inc., Phalanx Biotech Group, PhaseRx Inc., Prolias Technologies Inc., Qiagen N.V., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Rosetta Genomics Ltd., RXi Pharmaceuticals Corp., Sanofi U.S., Sarepta Therapeutics, Sigma-Aldrich Co. Llc, Silence Therapeutics Plc, Sirnaomics Inc., siRNAsense AS, Sylentis SA, Tacere Therapeutics Inc., Tekmira Pharmaceuticals Corp., Theradiag, Thermo Fisher Scientific Inc., and WaferGen Biosystems Inc.
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
TABLE OF CONTENT
1. Executive Summary
2. Scope of the Report
2.1 Market Overview
2.2 Product Offerings
3. Market Research Methodology
3.1 Market Research Process
3.2 Research Design
3.3 Research Methodology
4. List of Abbreviations
6. Market Landscape
6.1 Market Overview
7. Global MicroRNA Research Market
8. Global MicroRNA Market
8.1 Market Size and Forecast
8.2 Five Forces Analysis
9. Global MicroRNA Market Segmentation
9.1 Global MicroRNA Tools and Reagents Market
9.1.1 Market Size and Forecast
9.2 Global MicroRNA Therapeutics Market
9.2.1 Market Size and Forecast
9.3 Global MicroRNA Diagnostics Market
9.3.1 Market Size and Forecast
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.2 Key Vendor Ranking 2012
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Alnylam Pharmaceuticals Inc.
19.1.1 Business Overview
19.1.2 Business Segmentation
19.1.3 Key Information
19.1.4 SWOT Analysis
19.2 Exiqon A/S
19.2.1 Business Overview
19.2.2 Business Segmentation
19.2.3 Key Information
19.2.4 SWOT Analysis
19.3 Santaris Pharma A/S
19.3.1 Business Overview
19.3.2 Business Segmentation
19.3.3 Key Information
19.3.4 SWOT Analysis
20. Other Reports in this Series
List of TablesNA
List of Figures
Exhibit 1: Market Research Methodology
Exhibit 2: Market Segmentation
Exhibit 3: Market Segmentation by Geography
Exhibit 4: MicroRNA Research Publications
Exhibit 5: Models Employed for MicroRNA Research
Exhibit 6: Areas with MicroRNA Research
Exhibit 7: Global MicroRNA Market 2012-2016 (US$ million)
Exhibit 8: Global MicroRNA Market Segmentation
Exhibit 9: Global MicroRNA Market Segmentation 2012
Exhibit 10: Global MicroRNA Market Segmentation 2012-2016
Exhibit 11: Global MicroRNA Tools and Reagents Market 2012-2016 (US$ million)
Exhibit 12: Global MicroRNA Expression Profiling Market Segmentation by Type of Technology
Exhibit 13: Global MicroRNA Tools and Reagents Market Segmentation by Geography
Exhibit 14: Global MicroRNA Therapeutics Market 2012-2016 (US$ million)
Exhibit 15: Global MicroRNA Diagnostics Market 2012-2016 (US$ million)
Exhibit 16: Global MicroRNA Market Segmentation by Geography 2012
Exhibit 17: Business Segmentation of Alnylam Pharmaceuticals Inc.
Exhibit 18: Business segmentation of Exiqon A/S
Exhibit 19: Business Segmentation of Santaris Pharma A/S
Surgical Procedures Volumes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The amount of knowledge and information available about surgical care is very less in the context of public health care. Surgical procedure volumes include general surgical procedures to treat the minor illnesses as well as the advanced procedures using minimal invasive methods. Surgical safety has become a significant factor for public health considering the complications and incidences of death occurring during major surgeries. Surgery finds its applications in the areas such as cardiology, neurology, eye, ear and nose problems, urinary disorders, digestive disorders, orthopedics...
Physician Office Laboratory (POL) Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Physician office lab (POL) term is wide and diverse, it encompasses physician’s practices as small (2 to 5 doctors) to large practitioners (200 physicians) that operate labs similar to small laboratory hospitals. Hospitals and commercial labs perform tests, but physicians prefer to perform in-house testing in order to enhance the patient care. In-house testing facilitates physicians to no longer rely on the reference labs for test results. In addition, physicians can obtain faster results from their own labs and increase profits. POL also reduces the chances of loss or...
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal anti-inflammatory drugs. Although COX-2 is used in treatment of RA, it has several side effects associated with the upper gastrointestinal region. Currently, use of disease modifying antirheumatic drugs is recommended by most professionals in the early stages of disease. ...
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Select License type:
- Global and China Dispersion Machine Industry 2014 Market Research Report
- Global and China Multimedia hard disk Industry 2014 Market Research Report
- Global and China Water Pill Machine Industry 2014 Market Research Report
- Global and China Air Filter Industry 2014 Market Research Report
- Global and China Flash Type Extractor Industry 2014 Market Research Report
- Global and China Agitator Industry 2014 Market Research Report
- Global and China Distilled Water Device Industry 2014 Market Research Report
- Global and China Rotary Evaporator Industry 2014 Market Research Report
- Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014
- Macular Edema - Pipeline Review, H1 2014
Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year. Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai. The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis. Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods. This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015. Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...